(Q43752156)

26 November 2017

title

Biodistribution, binding specificity and metabolism of [18F]fluoroethylflumazenil in rodents (English)

1 reference

26 November 2017

Levêque P

1

1 reference

26 November 2017

Labar D

series ordinal

2

1 reference

26 November 2017

Gallez B

series ordinal

3

1 reference

26 November 2017

publication date

1 October 2001

1 reference

Nuclear Medicine and Biology

26 November 2017

published in

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

7

1 reference

26 November 2017

page(s)

809-814

1 reference

Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Effect of Cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffein

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Assessment of [18F]fluoroethylflumazenil metabolites using high-performance liquid chromatography and tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Synthesis of ethyl 8-fluoro-5,6-dihydro5- [11C]methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): A specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Binding of 5-(2'-[18F]fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Altered in vitro and in vivo flumazenil binding in human epileptogenic neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

[11C]flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900251-7

7 January 2021

10.1016/S0969-8051(01)00251-7

Identifiers

DOI

1 reference

26 November 2017

1 reference